Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS SUMMARY: Buy Dixons Carphone And AG Barr - Liberum

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Buy Dixons Carphone And AG Barr - Liberum

Mon, 04th May 2020 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

CITIGROUP CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 160 (165) PENCE - 'BUY'

----------

JPMORGAN CUTS RBS PRICE TARGET TO 180 (200) PENCE - 'OVERWEIGHT'

----------

UBS CUTS LLOYDS PRICE TARGET TO 45 (50) PENCE - 'BUY'

----------

CITIGROUP CUTS LLOYDS PRICE TARGET TO 42 (50) PENCE - 'BUY'

----------

BERENBERG RAISES LLOYDS PRICE TARGET TO 35 (34) PENCE - 'HOLD'

----------

CITIGROUP RAISES BARCLAYS PRICE TARGET TO 108 (106) PENCE - 'NEUTRAL'

----------

KEPLER CHEUVREUX RAISES RECKITT BENCKISER PRICE TARGET TO 7250 (6700) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES SEVERN TRENT PRICE TARGET TO 2250 (2160) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES J SAINSBURY PRICE TARGET TO 175 (170) PENCE - 'SELL'

----------

DEUTSCHE BANK CUTS INTERCONTINENTAL HOTELS TARGET TO 4300 (4600) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES ST JAMES'S PLACE PRICE TARGET TO 950 (930) PENCE - 'HOLD'

----------

BERENBERG RAISES POLYMETAL PRICE TARGET TO 1680 (1570) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES GLAXOSMITHKLINE PRICE TARGET TO 2060 (1900) PENCE - 'BUY'

----------

JPMORGAN CUTS AUTO TRADER GROUP PRICE TARGET TO 348 (368) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES UNILEVER PRICE TARGET TO 4300 (3850) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

LIBERUM RESUMES DIXONS CARPHONE WITH 'BUY' - PRICE TARGET 135 PENCE

----------

LIBERUM RAISES AG BARR TO 'BUY' ('HOLD') - PRICE TARGET 625 (580) PENCE

----------

BERENBERG RAISES INTEGRAFIN PRICE TARGET TO 500 (470) PENCE - 'BUY'

----------

JEFFERIES RAISES WEIR GROUP PRICE TARGET TO 1060 (1000) PENCE - 'HOLD'

----------

BARCLAYS CUTS 4IMPRINT GROUP PRICE TARGET TO 3300 (4800) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES HILTON FOOD TO 'BUY' ('HOLD') - TARGET 1320 PENCE

----------

BERENBERG RAISES HOCHSCHILD MINING PRICE TARGET TO 190 (170) PENCE - 'HOLD'

----------

BERENBERG RAISES CENTAMIN PRICE TARGET TO 172 (148) PENCE - 'BUY'

----------

RBC CUTS MARKS & SPENCER PRICE TARGET TO 120 (125) PENCE - 'OUTPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

MORGAN STANLEY CUTS ALLIED IRISH BANKS TARGET TO EUR1.50 (EUR3.25) - 'EQUAL-WEIGHT'

----------

LIBERUM RESUMES HOTEL CHOCOLAT WITH 'BUY' - TARGET 400 PENCE

----------

BERENBERG RAISES BREEDON PRICE TARGET TO 95 (85) PENCE - 'BUY'

----------

HSBC CUTS DART GROUP PRICE TARGET TO 880 (1710) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.